ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

2.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.00 1.95 2.05 2.00 2.00 2.00 108,096 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.38 15.51M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.95p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.51 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.38.

Shield Therapeutics Share Discussion Threads

Showing 5701 to 5723 of 23125 messages
Chat Pages: Latest  229  228  227  226  225  224  223  222  221  220  219  218  Older
DateSubjectAuthorDiscuss
30/4/2020
11:01
Perhaps they had a bid (although they should release that) but Carl wanted to hang on, or vice versa. I assume he retains his holding?
deeppockets
30/4/2020
10:57
At this rate might be heading for 100% rise today
78steve
30/4/2020
10:56
Something has got to be around the corner.

Big US deal

Big company eyeing Shield up now Carl has released his “baby” ?

peachie 74
30/4/2020
10:54
Perhaps chinese will come in knock out bid 275p.
montyhedge
30/4/2020
10:53
6 months ago I was topping up at this Level thinking I was definitely at the bottom !

Still away to go to levels we should be at imho. £2 min before news.

peachie 74
30/4/2020
10:46
Amazing rise today. Surely there must be something behind it.

Bizarrely in the early hours this morning, I was thinking about why Carl Sterrit left so precipitately. Yes I know, I am sad! But to carry on my thought process, the dramatic rise since the initial plunge after the news came out, suggests to me some corporate shenanigans going on behind the scene. I think there was a fundamental disagreement about strategy and my bet is that they are now looking for a buyer of the whole company. Pure speculation but the conclusion I came to at 4 this morning!

nobbygnome
30/4/2020
10:28
Something its seems about to happen, always someone knows more than us, shareprices talk and this shouting news shortly.
montyhedge
30/4/2020
10:25
Bubbling up nicely - 119.90/128.10 (IG)
Makes me wonder if CS was being obstinate ...

daveboy1
30/4/2020
10:24
Wonder why it's rising. Has there been a leak?
78steve
30/4/2020
10:24
We’re on board peachie lol for ages, certainly some usual activity, a few select investors must be hearing some pleasing news me thinks
ny boy
30/4/2020
09:27
Yep patience. If you’re holding ! This is running away atm if your not on board
peachie 74
30/4/2020
09:08
Onwards and upwards, stay safe - stay patient
ny boy
30/4/2020
09:06
Steve. The RNS did not make this go to 50.
It was an accumulation of

Covid scare
Griffiths sold millions at a time of no real volume. Only way he could sell was taking the price so far down. He has sold fair amounts over lots of shares recently.

The RNS about the H2H was an minor typo almost about inclusion data. Also it was only referencing GI patients. Shields product applies to all forms of iron deficiency. Edison maintained their 295 target after this.

But DYOR mate. With ANY share you never know what’s around the corner. Otherwise we would all be millionaires !

peachie 74
30/4/2020
09:01
Those are the people that deserve to, and do miss the bus to the party.
Top Asian pharma doesn't cough up millions up front on the basis of a flaky rns ...

daveboy1
30/4/2020
08:45
I think some people's confidence has been shaken due to recent rns that made it hit 50p makes you wonder what else will come to light. How do you tell if this is undervalued or not based on what i mean it's not based on actual sales numbers
78steve
30/4/2020
08:36
What a great chart....
nobbygnome
30/4/2020
08:24
Scary how quick this rises. Relatively small number of shares in PI hands.

People going to be left behind here very quickly if this continues

peachie 74
30/4/2020
07:51
Off we go again. I’ve said it before , these IMO are cheap as chips. DYOR , but we have a derisked treatment for the worlds biggest deficiency. It can compete with IV iron which requires hospitalisation etc
FDA BROAD label granted
ASK paying multi millions to expand us into China and Hong Kong
Patents for years
The rest of the world to conquer !

peachie 74
29/4/2020
18:23
They’ve not reported that they’ve submitted for pricing in any market since the H2H was released. There was an analysis released which said it was cost effective I think. No doubt in my mind they would be and they should get pricing if Norgine pulled its fat finger out.
crankyman
29/4/2020
18:18
Here you go best. To make you feel better !
peachie 74
28/4/2020
17:52
There’s not been any prices negotiated based on that data
crankyman
27/4/2020
21:30
Lako.... discussed previous

Cranky. Agree totally.

peachie 74
27/4/2020
20:59
Isn't there a potential issue here with Teva?

Doesn't seem to be mentioned?

lako42
Chat Pages: Latest  229  228  227  226  225  224  223  222  221  220  219  218  Older

Your Recent History

Delayed Upgrade Clock